Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQN6Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,064
Award facts
- Contract value 100% obligated
- $24,064.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,064.05 delivery order to AmerisourceBergen Drug Corp for Beyfortus 50 mg/0.5 mL syringes on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Beyfortus is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention, indicating this procurement supports federal military and healthcare system requirements for immunological products.
This delivery order is executed under AmerisourceBergen's prime IDC valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this expansive contract vehicle. The company's substantial federal portfolio demonstrates its capacity to fulfill diverse medical supply requirements, ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQN6Y?
SPE2DR26FQN6Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FQN6Y worth?
The government has obligated $24,064 on SPE2DR26FQN6Y.
Is contract SPE2DR26FQN6Y an order under another contract?
Yes. SPE2DR26FQN6Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN6Y competed?
The extent of competition for SPE2DR26FQN6Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award